Halozyme Therapeutics shares owned by CastleArk Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by CastleArk Management
from 13F filings
Historical chart of CastleArk Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by CastleArk Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by CastleArk Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $4.0M | 70k | 57.24 |
| 2023-12-31 | $4.3M | 116k | 36.96 |
| 2023-09-30 | $4.9M | 128k | 38.20 |
| 2022-12-31 | $12M | 206k | 56.90 |
| 2022-09-30 | $8.6M | 217k | 39.54 |
| 2022-06-30 | $9.0M | 204k | 44.00 |
| 2021-09-30 | $8.9M | 220k | 40.68 |
| 2021-06-30 | $14M | 318k | 45.41 |
| 2021-03-31 | $18M | 431k | 41.69 |
| 2020-12-31 | $21M | 499k | 42.71 |
| 2020-09-30 | $16M | 599k | 26.28 |
| 2020-06-30 | $15M | 561k | 26.81 |
| 2020-03-31 | $7.9M | 438k | 17.99 |
| 2018-06-30 | $7.1M | 423k | 16.87 |
| 2018-03-31 | $8.5M | 433k | 19.59 |
| 2017-12-31 | $7.1M | 350k | 20.26 |
| 2017-09-30 | $4.0M | 233k | 17.37 |